参考文献/References:
[1] ANTONETTI D,SILVA P S,STITT A W.Current understanding of the molecular and cellular pathology of diabetic retinopathy[J].Nat Rev Endocrinol,2021,17(4):195-206.
[2] HE M,CHEN H,WANG W.Refractive errors,ocular biometry and diabetic retinopathy:a comprehensive review[J].Curr Eye Res,2021,46(2):151-158.
[3] YU M D,ZHANG L J,SUN S S,ZHANG Z H.Gliquidone improves retinal injury to relieve diabetic retinopathy via regulation of SIRT1/Notch1 pathway[J].BMC Ophthalmol,2021,21(1):451.
[4] WANG H,ZHANG M,ZHOU H,CAO L,ZHOU J,CHEN Q,et al.Salusin-β mediates high glucose-induced inflammation and apoptosis in retinal capillary endothelial cells via a ROS-dependent pathway in diabetic retinopathy[J].Diabetes Metab Syndr Obes,2021,2021(14):2291-2308.
[5] LUO R,JIN H,LI L,HU Y X,XIAO F.Long noncoding RNA MEG3 inhibits apoptosis of retinal pigment epithelium cells induced by high glucose via the miR-93/Nrf2 axis[J].Am J Pathol,2020,190(9):1813-1822.
[6] TU Y,ZHU M,WANG Z,WANG K,CHEN L,LIU W,et al.Melatonin inhibits Müller cell activation and pro-inflammatory cytokine production via upregulating the MEG3/miR-204/Sirt1 axis in experimental diabetic retinopathy[J].J Cell Physiol,2020,235(11):8724-8735.
[7] LIU X,SU K,KUANG S,FU M,ZHANG Z.miR-16-5p and miR-145-5p trigger apoptosis in human gingival epithelial cells by down-regulating BACH2[J].Int J Clin Exp Pathol,2020,13(5):901-911.
[8] ZHANG J,CUI C,XU H.Downregulation of miR-145-5p elevates retinal ganglion cell survival to delay diabetic retinopathy progress by targeting FGF5[J].Biosci Biotechnol Biochem,2019,83(9):1655-1662.
[9] LIU D,LIU Y,ZHENG X,LIU N.c-MYC-induced long noncoding RNA MEG3 aggravates kidney ischemia-reperfusion injury through activating mitophagy by upregulation of RTKN to trigger the Wnt/β-catenin pathway[J].Cell Death Dis,2021,12(2):191-206.
[10] XU Y,ZHANG Y,LIANG H,LIU X.Coumestrol mitigates retinal cell inflammation,apoptosis,and oxidative stress in a rat model of diabetic retinopathy via activation of SIRT1[J].Aging (Albany NY),2021,13(4):5342-5357.
[11] 刘轩,程育宏,齐赟,崔丽珺,丁国龙,杨文,等.miR-939-5p对糖尿病视性网膜病变和视网膜微血管内皮细胞的调控作用[J].现代生物医学进展,2021,21(22):4249-4255,4307.
LIU X,CHENG Y H,QI Y,CUI L J,DING G L,YANG W,et al.Diabetic retinopathy MiR-939-5p Inducible nitric oxide synthase Human retinal microvascular endothelial cells[J].Prog Mod Biomed,2021,21(22):4249-4255,4307.
[12] VALDEZGUERRERO A S.QUINTANA-PREZ J C,ARELLANO-MENDOZA M G,CASTAEDA-IBARRA F J,TAMAY-CACH F,ALEMN-GONZLEZ-DUHART D.Diabetic retinopathy:important biochemical alterations and the main treatment strategies[J].Can J Diabetes,2021,45(6):504-511.
[13] AZAD R,SINHA S,NISHANT P.Asymmetric diabetic retinopathy[J].Indian J Ophthalmol,2021,69(11):3026-3034.
[14] ZHANG D,QIN H,LENG Y,LI X,ZHANG L,BAI D,et al.LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-β1 and VEGF[J].Exp Ther Med,2018,16(3):2337-2342.
[15] HE Y,DAN Y,GAO X,HUANG L,CHEN J.DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K/Akt/mTOR signaling pathway[J].Am J Physiol Endocrinol Metab,2021,320(3):E598-E608.
[16] ZOU C,GU C,ZHAO M,ZHU D,ZHANG Z.The role of the AIMP1 pathway in diabetic retinopathy:AIMP1-targeted intervention study in diabetic retinopathy[J].Ophthalmic Res,2020,63(2):122-132.
[17] ZHOU P,XIE W,MENG X,ZHAI Y,DONG X,ZHANG X,et al.Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy[J].Cells,2019,8(3):213-236.
[18] ZAMANIAN A M,REZAEI-TAVIRANI M,REZAEI-TAVIRANI M,ROBATI R M.Gestational diabetes mellitus regulatory network identifies hsa-miR-145-5p and hsa-miR-875-5p as potential biomarkers[J].Int J Endocrinol Metab,2019,17(3):e86640-e86646.
[19] JIANG L,WEI Z C,XU L L,YU S Y,LI C.Inhibition of miR-145-5p reduces spinal cord Injury-Induced inflammatory and oxidative stress responses via affecting Nurr1-TNF-α signaling axis[J].Cell Biochem Biophys,2021,79(4):791-799.
[20] SUN W,LOU H,CAO J,WANG P,SUN Q.LncRNA MEG3 control mycobacterium tuberculosis infection via controlled MiR-145-5p expression and modulation of macrophages proliferation[J].Microb Pathog,2020,149(4):104550-1045507.
相似文献/References:
[1]高亚莉,陆晓和.lncRNA-MEG3通过P53途径介导视网膜母细胞瘤凋亡[J].眼科新进展,2017,37(4):301.[doi:10.13389/j.cnki.rao.2017.0076]
GAO Ya-Li,LU Xiao-He.LncRNA-MEG3 mediated apoptosis of retinoblastoma by regulating P53 pathway[J].Recent Advances in Ophthalmology,2017,37(1):301.[doi:10.13389/j.cnki.rao.2017.0076]
[2]郎海波,黄敏丽.长链非编码RNA在糖尿病视网膜病变发展及治疗中的研究进展[J].眼科新进展,2019,39(5):482.[doi:10.13389/j.cnki.rao.2019.0111]
LANG Hai-Bo,HUANG Min-Li.Research progress of lncRNA in the development and treatment of diabetic retinopathy[J].Recent Advances in Ophthalmology,2019,39(1):482.[doi:10.13389/j.cnki.rao.2019.0111]
[3]白婷婷,杜红飞,许颖.老年性白内障患者血浆LncRNA生物标志物的筛选及鉴定[J].眼科新进展,2019,39(12):1171.[doi:10.13389/j.cnki.rao.2019.0269]
BAI Ting-Ting,DU Hong-Fei,XU Ying.Screening and identification of plasma LncRNA biomarkers for senile cataract[J].Recent Advances in Ophthalmology,2019,39(1):1171.[doi:10.13389/j.cnki.rao.2019.0269]
[4]李冠瑜,孙丰源.非编码RNA对葡萄膜黑色素瘤发生机制影响研究新进展[J].眼科新进展,2020,40(2):197.[doi:10.13389/j.cnki.rao.2020.0047]
LI Guanyu,SUN Fengyuan.Recent advances in mechanism of non-coding RNA in uveal melanoma[J].Recent Advances in Ophthalmology,2020,40(1):197.[doi:10.13389/j.cnki.rao.2020.0047]
[5]王中原,孙劲禹,谢田华,等.长链非编码RNA在糖尿病视网膜病变发病机制中的作用[J].眼科新进展,2020,40(5):487.[doi:10.13389/j.cnki.rao.2020.0112]
WANG Zhongyuan,SUN Jinyu,XIE Tianhua,et al.Research progress on role of lncRNA in diabetic retinopathy[J].Recent Advances in Ophthalmology,2020,40(1):487.[doi:10.13389/j.cnki.rao.2020.0112]
[6]王月,王雪,底煜.长链非编码RNA在早产儿视网膜病变中的作用研究进展[J].眼科新进展,2020,40(11):1097.[doi:10.13389/j.cnki.rao.2020.0244]
WANG Yue,WANG Xue,DI Yu.Research progress of long non-coding RNA in retinopathy of prematurity[J].Recent Advances in Ophthalmology,2020,40(1):1097.[doi:10.13389/j.cnki.rao.2020.0244]
[7]王坤,朱曼辉,陈莉莉,等.长链非编码RNA 母系表达基因3调控miR-34a对糖尿病视网膜病变Müller细胞活化及炎症因子分泌的影响[J].眼科新进展,2021,41(1):042.[doi:10.13389/j.cnki.rao.2021.0009]
WANG Kun,ZHU Manhui,CHEN Lili,et al.Effect of lncRNA MEG3 regulating miR-34a on the activation of Müller cells and the secretion of inflammatory cytokines in diabetic retinopathy[J].Recent Advances in Ophthalmology,2021,41(1):042.[doi:10.13389/j.cnki.rao.2021.0009]
[8]邵珺,王杨宁致,詹鹏飞.高糖环境下lncRNA MEG3对人视网膜血管内皮细胞增殖和迁移的作用及其机制[J].眼科新进展,2021,41(7):621.[doi:10.13389/j.cnki.rao.2021.0128]
SHAO Jun,WANGYANG Ningzhi,ZHAN Pengfei.Effects of lncRNA MEG3 on the growth and migration of human retinal microvascular endothelial cells under high glucose environment and its mechanisms[J].Recent Advances in Ophthalmology,2021,41(1):621.[doi:10.13389/j.cnki.rao.2021.0128]
[9]邱煜焱,杨旭,苟文军,等.2型糖尿病患者血清lncRNA MALAT1表达水平与视网膜病变的关系[J].眼科新进展,2022,42(12):971.[doi:10.13389/j.cnki.rao.2022.0199]
QIU Yuyan,YANG Xu,GOU Wenjun,et al.Relationship between the expression level of long non-coding ribonucleic acid metastasis associated lung adenocarcinoma transcript 1 in serum and retinopathy in patients with type 2 diabetes mellitus[J].Recent Advances in Ophthalmology,2022,42(1):971.[doi:10.13389/j.cnki.rao.2022.0199]